Results 21 to 30 of about 6,881 (206)

Knowledge and Opinions of Family Physicians in Denizli Regarding Deprescribing [PDF]

Eurasian Journal of Family Medicine
Aim: This study aims to assess the knowledge and opinions of family physicians in Denizli regarding deprescribing. Method: This descriptive study was conducted between January and April 2024, involving family physicians working at family health centers ...
Cagla Sila Nerkiz, Nilufer Emre, Aysun Ozsahin, Tamer Edirne   +3 more
doaj   +1 more source

Deprescribing Statins—Is It Ethical? [PDF]

Journal of the American Geriatrics Society, 2016
Non peer ...
openaire   +3 more sources

Attitudes of ambulatory care older Nepalese patients towards deprescribing and predictors of their willingness to deprescribe

Therapeutic Advances in Drug Safety, 2021
Introduction: Older adults continue to receive potentially inappropriate medications necessitating the need for medication optimization, by deprescribing.
Shakti Shrestha, Roshan Giri, Hari Prasad Sapkota, Siddhartha Sharma Danai, Ahsan Saleem, Shreeshab Devkota, Sagar Shrestha, Bhojraj Adhikari, Arjun Poudel   +8 more
doaj   +1 more source

Deprescribing in advanced illness [PDF]

Progress in Palliative Care, 2016
Patients with advanced illness such as cancer, chronic obstructive pulmonary disease, and Parkinson's disease experience acute symptoms and are usually prescribed medications to manage these, alongside drugs to treat other co-morbid, long-term conditions.
Akinbolade O, Husband A, Forrest S, Todd A   +3 more
openaire   +2 more sources

Delivering the right information to the right person at the right time to facilitate deprescribing in hospital: a mixed methods multisite study to inform decision support design in Australia

BMJ Open, 2019
Objectives To inform the design of electronic decision support (EDS) to facilitate deprescribing in hospitals we set out to (1) explore the current processes of in-hospital medicines review, deprescribing and communication of deprescribing decisions with
Melissa T Baysari, Wu Yi Zheng, Sarah Hilmer, Mai Duong, Amy Nguyen, Sarita Lo, Brendan Ng, Angus Ritchie, David Le Couteur, Andrew McLachlan, Alexandra Bennett   +10 more
doaj   +1 more source

Characterization of Anticholinergic Medication Use and Its Associations With Everyday Memory Problems and Cognitive Decline in Autistic Adults With Higher Support Needs

Autism Research, EarlyView.
ABSTRACT Among older adults in the general population, medications with anticholinergic (AC) effects are associated with declines in cognitive functioning and with dementia and Alzheimer's disease. Autistic people have high rates of co‐occurring medical conditions and polypharmacy across the lifespan; thus, they may be at particularly high risk of ...
Goldie A. McQuaid, Nancy Raitano Lee, Gregory L. Wallace   +2 more
wiley   +1 more source

The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people

BMC Geriatrics, 2018
The area of “deprescribing” has rapidly expanded in recent years as a positive intervention to reduce inappropriate polypharmacy and improve health outcomes for (older) people with multimorbidity. While our understanding of deprescribing as a process has
Adam Todd, Jesse Jansen, Jim Colvin, Andrew J. McLachlan   +3 more
doaj   +1 more source

Connecting the dots: A narrative review of the relationship between heart failure and cognitive impairment

ESC Heart Failure, Volume 12, Issue 2, Page 1119-1131, April 2025.
Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi, Maria Giulia Bellicini, Marianna Adamo, Andrea Pilotto, Marco Metra, Alessandro Padovani, Riccardo Proietti   +6 more
wiley   +1 more source

The benefits and harms of deprescribing [PDF]

Medical Journal of Australia, 2014
Deprescribing is the process of trial withdrawal of inappropriate medications. Currently, the strongest evidence for benefit of deprescribing is from cohort and observational studies of withdrawal of specific medication classes that have shown better patient outcomes, mainly through resolution of adverse drug reactions. Additional potential benefits of
Reeve, E., Shakib, S., Hendrix, I., Roberts, M., Wiese, M.   +4 more
openaire   +5 more sources

Outcomes of pharmacist‐led deprescribing interventions in older adults living in long‐term care facilities: a scoping review

Journal of Pharmacy Practice and Research, EarlyView.
Abstract Background An increase in the ageing population across long‐term care facilities (LTCFs) has led to an increased risk of polypharmacy. Pharmacist‐led deprescribing (PLD) can reduce these risks but there are limitations to its widespread uptake.
Sefunmi Odetola, Eileen Willis, Katrina Lane‐Krebs, Ashlyn Sahay   +3 more
wiley   +1 more source